Genomics Leader Will Lease the Entire 316,000
Square Foot Campus for Office Expansion
San Diego, CA – April
5, 2016 –
BioMed Realty today announced that Illumina, Inc. (NASDAQ: ILMN), a world
leader in genomics focused on improving human health by unlocking the power of
the genome, has signed a 10 year lease at BioMed Realty's i3 campus, a 316,000
square foot development currently under construction in the University Towne Centre
(UTC) life science market of San Diego. i3 will serve as expansion of Illumina's
headquarters, with move-in expected in July 2017.
i3 lease agreement marks the third major lease for new construction that BioMed
Realty and Illumina have completed within the last 15 months. Following completed
build-to-suit lease agreements for 360,000 square feet at Lincoln Centre in
Foster City, California, in, December 2014 and 155,000 square feet at Granta
Park in Cambridge, U.K., in June 2015, the i3 lease brings BioMed Realty to a
total of 831,000 square feet of premier laboratory and office space leased to
Illumina in California and the U.K. in less than a year and a half.
to i3 enables us to continue our growth in San Diego, our home city and a
source of top talent in our industry," said Marc Stapley, Executive Vice
President, Chief Administrative Officer and Chief Financial Officer at Illumina.
"i3 creates a near-term opportunity
for us to accommodate our growing teams in a location very close to our headquarters,
where we expect to reach full occupancy in the next year."
are thrilled to welcome Illumina to our i3 campus," said Alan D. Gold, Chief Executive
Officer of BioMed Realty. "Illumina's unmatched success and reputation as a
global leader in genomics is the perfect fit for this iconic campus, which will
bring together the key elements needed for their employees to thrive – flexible
design, great amenities and easy access to transportation. We look forward to
supporting Illumina's growth in San Diego as part of our continued and expanded
an atmosphere of connectivity, innovation and collaboration, the i3 campus will
be comprised of three 100,000 square foot customizable buildings. The campus
will include a variety of indoor and outdoor amenities, fuel cell energy
generation, and operable windows. With these elements, i3 is being built not
only to meet, but to surpass the requirements for LEED Platinum certification. The
campus core and shell construction is expected to be completed in July 2016.
addition to i3, BioMed Realty's UTC portfolio includes its Axiom campus,
formerly known as Towne Centre Technology Park, which BioMed Realty purchased
in 2015 and is redeveloping, and the adjacent UTC Campus @ Towne Centre, which
BioMed Realty acquired in April 2016.
more information about i3 and BioMed Realty's portfolio across the U.S. and U.K.,
please visit biomedrealty.com.
Realty invests in the highest quality institutional real estate to meet the
needs of the growing demand across the life science industry. The company owns
or has interests in properties comprising approximately 19.1 million rentable
square feet. Additional information is available at www.biomedrealty.com. Follow us on